HSV-1 amplicon vectors are an efficient gene transfer system for skeletal muscle cells

Current Gene Therapy

Volumn 6, Issue 3, 2006, Pages 371-381

  Wang, Yaming ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Cell therapy; Cre LoxP; Full length dystrophin; Gene therapy; HSV AAV hybrid amplicon; Muscle gene transfer; Myoblast transplantation; Site specific integration

Indexed keywords

BETA GALACTOSIDASE; CELL SURFACE RECEPTOR; COMPLEMENTARY DNA; CRE RECOMBINASE; DYSTROPHIN; ENHANCED GREEN FLUORESCENT PROTEIN; ION CHANNEL; PARVOVIRUS VECTOR; VIRUS VECTOR;

AMPLICON; AUTOLOGOUS STEM CELL TRANSPLANTATION; BASEMENT MEMBRANE; CELL CULTURE; CELL DIFFERENTIATION; CELL DIVISION; CELL SURVIVAL; CELL TRANSPLANTATION; DUCHENNE MUSCULAR DYSTROPHY; EX VIVO STUDY; GENE TRANSFER; GENETIC MANIPULATION; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; LOXP SITE; MEMBRANE PERMEABILITY; MOUSE; MUSCLE CELL; MYOBLAST; MYOPATHY; NONHUMAN; REVIEW; SKELETAL MUSCLE; STEM CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; VIRION;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HERPESVIRUS 1, HUMAN; HUMANS; MUSCLE FIBERS;

HUMAN HERPESVIRUS 1;

EID: 33745199839     PISSN: 15665232     EISSN: None     Source Type: Journal    
DOI: 10.2174/156652306777592108     Document Type: Review

References (77)

1. Akkaraju, G. R., Huard, J., Hoffman, E. P., Goins, W. F., Pruchnic, R., Watkins, S. C., Cohen, J. B. and Glorioso, J. C. (1999) Herpes simplex virus vector-mediated dystrophin gene transfer and expression in mdx mouse skeletal muscle. J. Gene Med., 1: 280-9.
2. Beam, K. G., Knudson, C. M. and Powell, J. A. (1986) A lethal mutation in mice eliminates the slow calcium current in skeletal muscle cells. Nature, 320: 168-70.
3. Bischoff, R. (1990) Cell cycle commitment of rat muscle satellite cells. J. Cell. Biol., 111: 201-7.
4. Braun, S. (2004) Naked plasmid DNA for the treatment of muscular dystrophy. Curr. Opin. Mol. Ther., 6: 499-505.
5. Bujold, M., Caron, N., Camiran, G., Mukherjee, S., Allen, P. D., Tremblay, J. P. and Wang, Y. (2002) Autotransplantation in mdx mice of mdx myoblasts genetically corrected by an hsv-1 amplicon vector. Cell. Transplant., 11: 759-67.
6. Chen, S. R., Ebisawa, K., Li, X. and Zhang, L. (1998) Molecular identification of the ryanodine receptor ca2+ sensor. J. Biol. Chem., 273: 14675-8.
7. Chen, S. R., Li, X., Ebisawa, K. and Zhang, L. (1997) Functional characterization of the recombinant type 3 ca2+ release channel (ryanodine receptor) expressed in hek293 cells. J. Biol. Chem., 272: 24234-46.
8. Dunckley, M. G., Love, D. R., Davies, K. E., Walsh, F. S., Morris, G. E. and Dickson, G. (1992) Retroviral-mediated transfer of a dystrophin mini-gene into mdx mouse myoblasts in vitro. FEBS Lett., 296: 128-34.
9. Dunckley, M. G., Wells, D. J., Walsh, F. S. and Dickson, G. (1993) Direct retroviral-mediated transfer of a dystrophin minigene into mdx mouse muscle in vivo. Hum. Mol. Genet., 2: 717-23.
10. Feero, W. G., Rosenblatt, J. D., Huard, J., Watkins, S. C., Epperly, M., Clemens, P. R., Kochanek, S., Glorioso, J. C., Partridge, T. A. and Hoffman, E. P. (1997) Viral gene delivery to skeletal muscle: Insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. Hum. Gene Ther., 8: 371-80.
11. Feng, W., Tu, J., Yang, T., Vernon, P. S., Allen, P. D., Worley, P. F. and Pessah, I. N. (2002) Homer regulates gain of ryanodine receptor type 1 channel complex. J. Biol. Chem., 277: 44722-30.
12. Fessenden, J. D., Chen, L., Wang, Y., Paolini, C., Franzini-Armstrong, C., Allen, P. D. and Pessah, I. N. (2001) Ryanodine receptor point mutant e4032a reveals an allosteric, interaction with ryanodine. Proc. Natl. Acad. Sci. USA, 98: 2865-70.
13. Fessenden, J. D., Feng, W., Pessah, I. N. and Allen, P. D. (2004) Mutational analysis of putative calcium binding motifs within the skeletal ryanodine receptor isoform, ryrl. J. Biol. Chem., 279: 53028-35.
14. Fessenden, J. D., Perez, C. F., Goth, S., Pessah, I. N. and Allen, P. D. (2003) Identification of a key determinant of ryanodine receptor type 1 required for activation by 4-chloro-m-cresol. J. Biol. Chem., 278: 28727-35.
15. Fessenden, J. D., Wang, Y., Moore, R. A., Chen, S. R., Allen, P. D. and Pessah, I. N. (2000) Divergent functional properties of ryanodine receptor types 1 and 3 expressed in a myogenic cell line. Biophys. J., 79: 2509-25.
16. Floyd, S. S. Jr., Clemens, P. R., Ontell, M. R., Kochanek, S., Day, C. S., Yang, J., Hauschka, S. D., Balkir, L., Morgan, J., Moreland, M. S., Feero, G. W., Epperly, M. and Huard, J. (1998) ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles. Gene Ther., 5: 19-30.
17. Fraefel, C., Song, S., Lim, F., Lang, P., Yu, L., Wang, Y., Wild, P. and Geller, A. I. (1996) Helper virus-free transfer of herpes simplex virus type 1 plasmid vectors into neural cells. J. Virol., 70: 7190-7.
18. Goldspink, G. (2003) Skeletal muscle as an artificial endocrine tissue. Best Pract. Res. Clin. Endocrinol. Metab., 17: 211-22.
19. Gregg, R. G., Messing, A., Strube, C., Beurg, M., Moss, R., Behan, M., Sukhareva, M., Haynes, S., Powell, J. A., Coronado, R. and Powers, P. A. (1996) Absence of the beta subunit (cchb1) of the skeletal muscle dihydropyridine receptor alters expression of the alpha 1 subunit and eliminates excitation-contraction coupling. Proc. Natl. Acad. Sci. USA, 93: 13961-6.
20. Gregorevic, P., Blankinship, M. J. and Chamberlain, J. S. (2004) Viral vectors for gene transfer to striated muscle. Curr. Opin. Mol. Ther., 6: 491-8.
21. Gussoni, E., Blau, H. M. and Kunkel, L. M. (1997) The fate of individual myoblasts after transplantation into muscles of dmd patients. Nat. Med., 3: 970-7.
22. Gussoni, E., Pavlath, G. K., Lanctot, A. M., Sharma, K. R., Miller, R. G., Steinman, L. and Blau, H. M. (1992) Normal dystrophin transcripts detected in duchenne muscular dystrophy patients after myoblast transplantation. Nature, 356: 435-8.
23. Heister, T., Heid, I., Ackermann, M. and Fraefel, C. (2002) Herpes simplex virus type 1/adeno-associated virus hybrid vectors mediate site-specific integration at the adeno-associated virus preintegration site, aavs1, on human chromosome 19. J. Virol., 76: 7163-73.
24. High, K. A. (2003) Theodore e. Woodward award. Aav-mediated gene transfer for hemophilia. Trans. Am. Clin. Climatol. Assoc., 114: 337-51; discussion 351-2.
25. Hoffman, E. P., Brown, R. H., Jr. and Kunkel, L. M. (1987) Dystrophin: The protein product of the duchenne muscular dystrophy locus. Cell, 51: 919-28.
26. Huard, J., Akkaraju, G., Watkins, S. C., Pike-Cavalcoli, M. and Glorioso, J. C. (1997a) Lacz gene transfer to skeletal muscle using a replication-defective herpes simplex virus type 1 mutant vector. Hum. Gene Ther., 8: 439-52.
27. Huard, J., Feero, W. G., Watkins, S. C., Hoffman, E. P., Rosenblatt, D. J. and Glorioso, J. C. (1996) The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers. J. Virol., 70: 8117-23.
28. Huard, J., Goins, W. F. and Glorioso, J. C. (1995) Herpes simplex virus type 1 vector mediated gene transfer to muscle. Gene Ther., 2: 385-92.
29. Huard, J., Krisky, D., Oligino, T., Marconi, P., Day, C. S., Watkins, S. C. and Glorioso, J. C. (1997b) Gene transfer to muscle using herpes simplex virus-based vectors. Neuromuscul. Disord., 7: 299-313.
30. Huard, J., Roy, R., Bouchard, J. P., Malouin, F., Richards, C. L. and Tremblay, J. P. (1992) Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions. Transplant. Proc., 24: 3049-51.
31. Huard, J., Tremblay, G., Verreault, S., Labrecque, C. and Tremblay, J. P. (1993) Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice. Cell Transplant., 2: 113-8.
32. Hurne, A. M., O'brien, J. J., Wingrove, D., Cherednichenko, G., Allen, P. D., Beam, K. G. and Pessah, I. N. (2005) Ryanodine receptor type 1 (ryr1) mutations c4958s and c4961s reveal excitation-coupled calcium entry (ecce) is independent of sarcoplasmic reticulum store depletion. J. Biol. Chem., 280: 36994-7004.
33. Karpati, G., Ajdukovic, D., Arnold, D., Gledhill, R. B., Guttmann, R., Holland, P., Koch, P. A., Shoubridge, E., Spence, D., Vanasse, M. and et al., (1993) Myoblast transfer in duchenne muscular dystrophy. Ann. Neurol., 34: 8-17.
34. Karpati, G., Pouliot, Y., Zubrzycka-Gaarn, E., Carpenter, S., Ray, P. N., Worton, R. G. and Holland, P. (1989) Dystrophin is expressed in mdx skeletal muscle fibers after normal myoblast implantation. Am. J. Pathol., 135: 27-32.
35. Kinoshita, I., Vilquin, J. T., Guerette, B., Asselin, I., Roy, R. and Tremblay, J. P. (1994) Very efficient myoblast allotransplantation in mice under fk506 immunosuppression. Muscle Nerve., 17: 1407-15.
36. Kiselyov, K. I., Shin, D. M., Wang, Y., Pessah, I. N., Allen, P. D. and Muallem, S. (2000) Gating of store-operated channels by conformational coupling to ryanodine receptors. Mol. Cell., 6: 421-31.
37. Law, P. K. (1993) Myoblast transfer therapy. Lancet, 341: 247.
38. Law, P. K., Goodwin, T. G., Fang, Q., Hall, T. L., Quinley, T., Vastagh, G., Duggirala, V., Larkin, C., Florendo, J. A., Li, L., Jackson, T., Yoo, T. J., Chase, N., Neel, M., Krahn, T. and Holcomb, R. (1997) First human myoblast transfer therapy continues to show dystrophin after 6 years. Cell. Transplant., 6: 95-100.
39. Law, P. K., Goodwin, T. G. and Wang, M. G. (1988) Normal myoblast injections provide genetic treatment for murine dystrophy. Muscle Nerve., 11: 525-33.
40. Lee, E. H., Lopez, J. R., Li, J., Protasi, F., Pessah, I. N., Kim Do, H. and Allen, P. D. (2004a) Conformational coupling of dhpr and ryr1 in skeletal myotubes is influenced by long-range allosterism: Evidence for a negative regulatory module. Am. J. Physiol. Cell. Physiol., 286: C179-89.
41. Lee, E. H., Rho, S. H., Kwon, S. J., Eom, S. H., Allen, P. D. and Kim Do, H. (2004b) N-terminal region of fkbp12 is essential for binding to the skeletal ryanodine receptor. J. Biol. Chem., 279: 26481-8.
42. Liu, Q., Perez, C. F. and Wang, Y. (2006) Efficient site-specific integration of large transgenes by an enhanced herpes simplex virus/ adeno-associated virus hybrid amplicon vector. J. Virol., 80: 1672-9.
43. Lu, Q. L., Bou-Gharios, G. and Partridge, T. A. (2003) Non-viral gene delivery in skeletal muscle: A protein factory. Gene Ther., 10: 131-42.
44. Ma, J., Bhat, M. B. and Zhao, J. (1995) Rectification of skeletal muscle ryanodine receptor mediated by fk506 binding protein. Biophys. J., 69: 2398-404.
45. Mauro, A. (1961) Satellite cell of skeletal muscle fibers. J. Biophys. Biochem. Cytol., 9: 493-5.
46. Mcmahon, J. M. and Wells, D. J. (2004) Electroporation for gene transfer to skeletal muscles: Current status. BioDrugs, 18: 155-65.
47. Mendell, J. R., Kissel, J. T., Amato, A. A., King, W., Signore, L., Prior, T. W., Sahenk, Z., Benson, S., Mcandrew, P. E., Rice, R. and et al., (1995) Myoblast transfer in the treatment of duchenne's muscular dystrophy. N. Engl. J. Med., 333: 832-8.
48. Nakai, J., Dirksen, R. T., Nguyen, H. T., Pessah, I. N., Beam, K. G. and Allen, P. D. (1996) Enhanced dihydropyridine receptor channel activity in the presence of ryanodine receptor. Nature, 380: 72-5.
49. Oehmig, A., Fraefel, C., Breakefield, X. O. and Ackermann, M. (2004) Herpes simplex virus type 1 amplicons and their hybrid virus partners, ebv, aav, and retrovirus. Curr. Gene Ther., 4: 385-408.
50. Partridge, T. A., Morgan, J. E., Coulton, G. R., Hoffman, E. P. and Kunkel, L. M. (1989) Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts. Nature, 337: 176-9.
51. Pavlath, G. K., Rando, T. A. and Blau, H. M. (1994) Transient immunosuppressive treatment leads to long-term retention of allogeneic myoblasts in hybrid myofibers. J. Cell. Biol., 127: 1923-32.
52. Perez, C. F., Lopez, J. R. and Allen, P. D. (2005) Expression levels of ryr1 and ryr3 control resting free ca2+ in skeletal muscle. Am. J. Physiol. Cell. Physiol., 288: C640-9.
53. Perez, C. F., Mukherjee, S. and Allen, P. D. (2003a) Amino acids 1-1,680 of ryanodine receptor type 1 hold critical determinants of skeletal type for excitation-contraction coupling. Role of divergence domain d2. J. Biol. Chem., 278: 39644-52.
54. Perez, C. F., Voss, A., Pessah, I. N. and Allen, P. D. (2003b) Ryr1/ryr3 chimeras reveal that multiple domains of ryr1 are involved in skeletal-type e-c coupling. Biophys. J., 84: 2655-63.
55. Proenza, C., O'brien, J., Nakai, J., Mukherjee, S., Allen, P. D. and Beam, K. G. (2002) Identification of a region of ryr1 that participates in allosteric coupling with the alpha(1s) (ca(v)1.1) ii-iii loop. J. Biol. Chem., 277: 6530-5.
56. Protasi, F., Paolini, C., Nakai, J., Beam, K. G., Franzini-Armstrong, C. and Allen, P. D. (2002) Multiple regions of ryr1 mediate functional and structural interactions with alpha(1s)-dihydropyridine receptors in skeletal muscle. Biophys. J., 83: 3230-44.
57. Protasi, F., Shtifman, A., Julian, F. J. and Allen, P. D. (2004) All three ryanodine receptor isoforms generate rapid cooling responses in muscle cells. Am. J. Physiol. Cell. Physiol., 286: C662-70.
58. Protasi, F., Takekura, H., Wang, Y., Chen, S. R., Meissner, G., Allen, P. D. and Franzini-Armstrong, C. (2000) Ryr1 and ryr3 have different roles in the assembly of calcium release units of skeletal muscle. Biophys. J., 79: 2494-508.
59. Rando, T. A. and Blau, H. M. (1994) Primary mouse myoblast purification, characterization, and transplantation for cell-mediated gene therapy. J. Cell. Biol., 125: 1275-87.
60. Recchia, A., Parks, R. J., Lamartina, S., Toniatti, C., Pieroni, L., Palombo, F., Ciliberto, G., Graham, F. L., Cortese, R., La Monica, N. and Colloca, S. (1999) Site-specific integration mediated by a hybrid adenovirus/adeno-associated virus vector. Proc. Natl. Acad. Sci. USA, 96: 2615-20.
61. Roy, R., Tremblay, J. P., Huard, J., Richards, C., Malouin, F. and Bouchard, J. P. (1993) Antibody formation after myoblast transplantation in duchenne-dystrophic patients, donor hla compatible. Transplant. Proc., 25: 995-7.
62. Schultz, E., Jaryszak, D. L. and Valliere, C. R. (1985) Response of satellite cells to focal skeletal muscle injury. Muscle Nerve., 8: 217-22.
63. Starr, P. A., Lim, F., Grant, F. D., Trask, L., Lang, P., Yu, L. and Geller, A. I. (1996) Long-term persistence of defective hsv-1 vectors in the rat brain is demonstrated by reactivation of vector gene expression. Gene Ther., 3: 615-23.
64. Stripecke, R., Carmen Villacres, M., Skelton, D., Satake, N., Halene, S. and Kohn, D. (1999) Immune response to green fluorescent protein: Implications for gene therapy. Gene Ther., 6: 1305-12.
65. Takeshima, H. (1993) Primary structure and expression from cdnas of the ryanodine receptor. Ann. N. Y. Acad. Sci., 707: 165-77.
66. Takeshima, H., Iino, M., Takekura, H., Nishi, M., Kuno, J., Minowa, O., Takano, H. and Noda, T. (1994) Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor Gene. Nature, 369: 556-9.
67. Takeshima, H., Ikemoto, T., Nishi, M., Nishiyama, N., Shimuta, M., Sugitani, Y., Kuno, J., Saito, I., Saito, H., Endo, M., Iino, M. and Noda, T. (1996) Generation and characterization of mutant mice lacking ryanodine receptor type 3. J. Biol. Chem., 271: 19649-52.
68. Tsai, D. J., Ho, J. J., Ozawa, C. R. and Sapolsky, R. M. (2000) Long-term expression driven by herpes simplex virus type-1 amplicons may fail due to eventual degradation or extrusion of introduced transgenes. Exp. Neurol., 165: 58-65.
69. Wang, L. and Herzog, R. W. (2005) Aav-mediated gene trunsfer for treatment of hemophilia. Curr. Gene Ther., 5: 349-60.
70. Wang, Y., Camp, S. M., Niwano, M., Shen, X., Bakowska, J. C., Breakefield, X. O. and Allen, P. D. (2002a) Herpes simplex virus type 1/ adeno-associated virus rep(+) hybrid amplicon vector improves the stability of transgene expression in human cells by site-specific integration. J. Virol., 76: 7150-62.
71. Wang, Y., Fraefel, C., Protasi, F., Moore, R. A., Fessenden, J. D., Pessah, I. N., Difrancesco, A., Breakefield, X. and Allen, P. D. (2000) Hsv-1 amplicon vectors are a highly efficient gene delivery system for skeletal muscle myoblasts and myotubes. Am. J. Physiol. Cell. Physiol., 278: C619-26.
72. Wang, Y., Mukherjee, S., Fraefel, C., Breakefield, X. O. and Allen, P. D. (2002b) Herpes simplex virus type 1 amplicon vector-mediated gene transfer to muscle. Hum. Gene Ther., 13: 261-73.
73. Ward, C. W., Protasi, F., Castillo, D., Wang, Y., Chen, S. R., Pessah, I. N., Allen, P. D. and Schneider, M. F. (2001) Type 1 and type 3 ryanodine receptors generate different ca(2+) release event activity in both intact and permeabilized myotubes. Biophys. J., 81: 3216-30.
74. Ward, C. W., Schneider, M. F., Castillo, D., Protasi, F., Wang, Y., Chen, S. R. and Allen, P. D. (2000) Expression of ryanodine receptor ryr3 produces ca2+ sparks in dyspedic myotubes. J. Physiol., 525 Pt 1: 91-103.
75. Wolff, J. A., Malone, R. W., Williams, P., Chong, W., Acsadi, G., Jani, A. and Felgner, P. L. (1990) Direct gene transfer into mouse muscle in vivo. Science, 247: 1465-8.
76. Yang, T., Ta, T. A., Pessah, I. N. and Allen, P. D. (2003) Functional defects in six ryanodine receptor isoform-1 (ryr1) mutations associated with malignant hyperthermia and their impact on skeletal excitation-contraction coupling. J. Biol. Chem., 278: 25722-30.
77. Yeung, S., Bockhold, K. and Tufaro, F. (1999) Efficient infection of mature skeletal muscle with herpes simplex virus vectors by using dextran sulfate as a co-receptor. Gene Ther., 6: 1536-44.